Company news

Sensorion SAS news in 2026

Sensorion SAS's news releases, calls and decks from 2026, newest first.

View company

Sensorion Announces the Appointment of Louis J. Arcudi III as Chief Financial Officer

October 7, 2026

Sensorion Reports 2026 Half-Year Results, Provides Corporate Update and Announces Availability of Half-Year Report

September 23, 2026

Sensorion Announces Connection Details for its SENS-601 Program Day on September 22, 2026

September 18, 2026

Sensorion Announces Confidential Submission of Draft Registration Statement to the SEC for Potential U.S. Initial Public Offering

September 16, 2026

Sensorion Announces the Completion of Its Reverse Share Split

September 15, 2026

Sensorion Announces Approval of Clinical Trial Application in France for SENS-601, Its Investigational Gene Therapy for the Treatment of GJB2-Related Hearing Loss

September 3, 2026

Sensorion Announces a Reverse Share Split of its Shares

July 29, 2026

Sensorion Achieves Key Regulatory Milestones for SENS-601 for GJB2-related Hearing Loss and Selects Program as Lead Gene Therapy Candidate

June 10, 2026

Sensorion Appoints Fred Chereau as Chief Executive Officer

May 18, 2026

Sensorion Announces its Participation in the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

May 5, 2026

Sensorion Provides Preliminary Documents for the Combined Shareholders’ General Meeting of May 11, 2026

April 21, 2026

Sensorion Reports Six-Month Update from the Audiogene Phase 1/2 Trial of SENS-501 and Advances GJB2-GT (SENS-601) Toward First-in-Human Clinical Development

March 23, 2026

Sensorion Reports Full-Year 2025 Results, Provides Corporate Update and Announces Release of Annual Report

March 18, 2026

Sensorion Announces Leadership Changes

February 17, 2026

Sensorion Announces its Participation in the Association for Research in Otolaryngology ARO 49th Annual Midwinter Meeting

February 6, 2026

Sensorion Announces EUR60 Million Financing with a EUR20M Strategic Investment from Sanofi and Support from Global Healthcare Specialists to Advance Genetic Medicine Pipeline

January 29, 2026

Sensorion Announces €60 Million Financing With a €20M Strategic Investment from Sanofi and Support from Global Healthcare Specialists To Advance Genetic Medicine Pipeline

January 28, 2026

Decks in 2026